Company Filing History:
5 out of 6 
3 out of 3 
1 out of 1,744 
Years Active: 2016-2023
Title: Fabienne Vernejoul: Innovator in Immunomodulatory Compounds
Introduction
Fabienne Vernejoul is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of immunology through her innovative research and development of novel compounds. With a total of 9 patents to her name, Vernejoul is recognized for her work in cytokine induction and therapeutic applications.
Latest Patents
Vernejoul's latest patents include groundbreaking inventions such as "Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction." This invention provides a Pro-cyclic dinucleotide (Pro-CDN) that comprises a STING agonist cyclic dinucleotide coupled to a linker system. The Pro-CDNs can be metabolized at targeted sites to exert their full immunomodulatory effects. Additionally, she has developed cyclic dinucleotide compounds that can be used in the treatment of bacterial infections, viral infections, and cancers.
Career Highlights
Throughout her career, Fabienne Vernejoul has worked with notable companies such as Invivogen and Kayla Therapeutics. Her work has focused on developing innovative solutions to combat various diseases, particularly in the realm of immunology. Her research has led to advancements that have the potential to improve treatment outcomes for patients suffering from immunological disorders.
Collaborations
Vernejoul has collaborated with esteemed colleagues in her field, including Thierry Lioux and Gerard Tiraby. These collaborations have further enhanced her research and contributed to the development of her patented inventions.
Conclusion
Fabienne Vernejoul is a trailblazer in the field of immunology, with a strong portfolio of patents that reflect her innovative spirit and dedication to advancing medical science. Her contributions continue to pave the way for new therapeutic approaches in treating complex diseases.